Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
675,400
-
Share change
-
-53,501
-
Total reported value
-
$121,103,434
-
Price per share
-
$179.11
-
Number of holders
-
116
-
Value change
-
-$9,710,803
-
Number of buys
-
28
-
Number of sells
-
51
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q2 2023
As of 30 Jun 2023,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
116 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
675,400 shares.
The largest 10 holders included
RAYMOND JAMES & ASSOCIATES, MORGAN STANLEY, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Royal Bank of Canada, Fisher Asset Management, LLC, BROWN ADVISORY INC, BANK OF AMERICA CORP /DE/, LPL Financial LLC, ENVESTNET ASSET MANAGEMENT INC, and WELLS FARGO & COMPANY/MN.
This page lists
118
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.